Clinicopathologic significance of hypoxia-inducible factor 1α overexpression in gastric carcinomas

Journal of Surgical Oncology

Volumn 94, Issue 2, 2006, Pages 149-154

  Mizokami, Ken ^a,c   Kakeji, Yoshihiro ^a   Oda, Shinya ^a   Irie, Koji ^b   Yonemura, Tomohiro ^b   Konishi, Fumio ^c   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Saga Prefectural Hospital Koseikan   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Gastric carcinoma; HIF 1 ; IGF 2; Microvessel density; Prognosis; VEGF

Indexed keywords

CD34 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SOMATOMEDIN B; VASCULOTROPIN; VASCULOTROPIN A;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CLINICAL FEATURE; CORRELATION ANALYSIS; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CARCINOMA; SURVIVAL RATE; TUMOR VASCULARIZATION; TUMOR VOLUME; ANOXIA; BIOSYNTHESIS; GASTRECTOMY; GENETICS; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; STOMACH TUMOR; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANOXIA; FEMALE; GASTRECTOMY; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR II; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; STOMACH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33747097563     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20568     Document Type: Article

References (23)

1. Brown JM: Exploiting the hypoxic cancer cell: Mechanisms and therapeutic strategies. Mol Med Today 2000;6:157-162.
2. Brizel DM, Scully SP, Harrelson JM, et al.: Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 1996;56:941-943.
3. Semenza GL: HIF-1 and human disease: One highly involved factor. Genes Dev 2000;14:1983-1991.
4. Wenger RH: Mammalian oxygen sensing, signalling and gene regulation. J Exp Biol 2000;203:1253-1263.
5. Forsythe JA, Jiang BH, Iyer NV, et al.: Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996;16:4604-4613.
6. 2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 1998;12:149-162.
7. Feldser D, Agani F, Iyer NV, et al.: Reciprocal positive regulation of hypoxia-inducible factor 1 {{alpha}} and insulin-like growth factor 2. Cancer Res 1999;59:3915-7113.
8. Wu MS, Wang HP, Lin CC, et al.: Loss of imprinting and overexpression of IGF2 gene in gastric adenocarcinoma. Cancer Lett 1997;120:9-14.
9. Kim KS, Lee YI: Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma. Cancer Lett 1997;119:143-148.
10. Japanese Research Society for Gastric Cancer. Japanese classification of gastric carcinoma. Tokyo: Kanehara and Co., Ltd. 1995;12:1995.
11. Zhong H, De Marzo AM, Laughner E, et al.: Overexpression of hypoxia-inducible factor 1 {{alpha}} in common human cancers and their metastases. Cancer Res 1999;59:5830-7113.
12. Semenza GL: HIF-1 and tumor progression: Pathophysiology and therapeutics. Trends Mol Med 2002;8:S62-67.
13. Weidner N, Semple JP, Welch WR, et al.: Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
14. Zagzag D, Zhong H, Scalzitti JM, et al.: Expression of hypoxia-inducible factor 1alpha in brain tumors: Association with angiogenesis, invasion, and progression. Cancer 2000;88:2606-2618.
15. Stoeltzing O, McCarty MF, Wey JS, et al.: Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation. J Natl Cancer Inst 2004;96:946-956.
16. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 1998;95:7987-7992.
17. Buchler P, Reber HA, Buchler M, et al.: Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer. Pancreas 2003;26:56-64.
18. Shiraishi T, Mori M, Yamagata M, et al.: Expression of insulin-like growth factor 2 mRNA in human gastric cancer. Int J Oncol 1998;13:519-523.
19. Yi HK, Hwang PH, Yang DH, et al.: Expression of the insulin-like growth factors (IGFs) and the IGF-binding proteins (IGFBPs) in human gastric cancer cells. Eur J Cancer 2001;37:2257-2263.
20. Tanigawa N, Amaya H, Matsumura M, et al.: Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma. J Clin Oncol 1997;15:826-832.
21. Takahashi R, Tanaka S, Hiyama T, et al.: Hypoxia-inducible factor-1 alpha expression and angiogenesis in gastrointestinal stromal tumor of the stomach. Oncol Rep 2003;10:797-802.
22. Kung AL, Wang S, Klco JM, et al.: Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat Med 2000;6:1335-1340.
23. Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003;3:721-732.